Phase
Condition
Heartburn (Pediatric)
Esophageal Disorders
Heartburn
Treatment
personalized exclusion diet based on CLE
empiric exclusion diet
Clinical Study ID
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Eosinophilic Esophagitis, with peak eosinophil count of >15 eos/HPF and symptoms ofdysphagia at least 2 days per week
Patients have had a trial of high-dose PPI for at least 8 weeks, with eitherdocumented non-response or intolerance to the medication
Patients aged between 18 and 70 years old
Signed written informed consent
Eosinophilic Esophagitis, with peak eosinophil count of >15 eos/HPF and symptoms ofdysphagia at least 2 days per week
Patients have had a trial of high-dose PPI for at least 8 weeks, with eitherdocumented non-response or intolerance to the medication
Patients aged between 18 and 70 years old
Signed written informed consent
Exclusion
Exclusion criteria:
IgE-mediated food anaphylaxis for 1 of the trigger nutrients
History of major gastrointestinal surgery complicating esophago-gastro-duodenoscopy
Gastro-esophageal reflux disease (GERD) Los Angeles grade C or D
Esophageal strictures, too narrow to pass with a normal gastroscope
Endoscopic dilation in the esophagus in the 4 weeks prior to inclusion
Celiac disease
Recent use (within two weeks) of non-steroidal anti-inflammatory drugs (NSAIDs),systemic histamine-receptor antagonists, mast cell stabilizers, opioids.
Proton pump inhibitors must be either stopped for at least 4 weeks, or continued ona stable dosage throughout the study period.
Corticosteroids should be stopped for at least 4 weeks.
Allergy to fluorescein, Xylocain or Propofol
Pregnant or lactating women
Study Design
Study Description
Connect with a study center
Jan Tack
Leuven, Vlaams Brabant 3000
BelgiumActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.